Cargando…

Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report

BACKGROUND: The purpose of this study was to elucidate the effects of glimepiride on the levels of biomarkers related to cardiovascular regulation in patients with type 2 diabetes mellitus. METHODS AND RESULTS: Thirty-four patients with type 2 diabetes received glimepiride for 24 weeks. Significant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Ikuko, Oyama, Jun-ichi, Komoda, Hiroshi, Shiraki, Aya, Sakamoto, Yoshiko, Taguchi, Isao, Hiwatashi, Atsushi, Komatsu, Aiko, Takeuchi, Masayoshi, Yamagishi, Sho-ichi, Inoue, Teruo, Node, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909938/ https://www.ncbi.nlm.nih.gov/pubmed/24423092 http://dx.doi.org/10.1186/1475-2840-13-15

Ejemplares similares

Effects of sitagliptin beyond glycemic control: focus on quality of life
por: Sakamoto, Yoshiko, et al.
Publicado: (2013)

Deletion of Apoptosis Inhibitor of Macrophage (AIM)/CD5L Attenuates the Inflammatory Response and Infarct Size in Acute Myocardial Infarction
por: Nishikido, Toshiyuki, et al.
Publicado: (2016)

Azelnidipine Inhibits the Differentiation and Activation of THP-1 Macrophages through the L-Type Calcium Channel
por: Komoda, Hiroshi, et al.
Publicado: (2018)

Pentraxin-3 regulates the inflammatory activity of macrophages
por: Shiraki, Aya, et al.
Publicado: (2016)

COA-Cl (2-Cl-C.OXT-A) can promote coronary collateral development following acute myocardial infarction in mice
por: Nishikido, Toshiyuki, et al.
Publicado: (2019)

GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy
por: Shiraki, Aya, et al.
Publicado: (2019)

A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction
por: Kitsuka, Takahiro, et al.
Publicado: (2022)

Author Correction: A novel soluble epoxide hydrolase vaccine protects murine cardiac muscle against myocardial infarction
por: Kitsuka, Takahiro, et al.
Publicado: (2022)

Cancer Malignancy Is Enhanced by Glyceraldehyde-Derived Advanced Glycation End-Products
por: Takino, Jun-Ichi, et al.
Publicado: (2010)

Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy
por: Takeuchi, Masayoshi, et al.
Publicado: (2010)

Rheumatoid Arthritis and Vascular Failure - Rheumatoid Arthritis Is a Risk Factor for Cardiovascular Disease-
por: Oyama, Jun-ichi, et al.
Publicado: (2019)

Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men
por: Tahara, Nobuhiro, et al.
Publicado: (2010)

N-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Do incretins improve endothelial function?
por: Oyama, Jun-ichi, et al.
Publicado: (2014)

Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Postprandial hyperglycemia as an etiological factor in vascular failure
por: Node, Koichi, et al.
Publicado: (2009)

Mobilization of progenitor cells and assessment of vessel healing after second generation drug-eluting stenting by optical coherence tomography
por: Sakuma, Masashi, et al.
Publicado: (2018)

Effects of canagliflozin in patients with type 2 diabetes and chronic heart failure: a randomized trial (CANDLE)
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan
por: Takeuchi, Masayoshi, et al.
Publicado: (2015)

Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study
por: Kato, Toru, et al.
Publicado: (2010)

Atorvastatin Reduces Proteinuria in Non-Diabetic Chronic Kidney Disease Patients Partly via Lowering Serum Levels of Advanced Glycation End Products (AGEs)
por: Nakamura, Tsukasa, et al.
Publicado: (2010)

Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial
por: Tanaka, Atsushi, et al.
Publicado: (2016)

Comparing the Effects of Canagliflozin vs. Glimepiride by Body Mass Index in Patients with Type 2 Diabetes and Chronic Heart Failure: A Subanalysis of the CANDLE Trial
por: Sezai, Akira, et al.
Publicado: (2022)

Comment on: Monami et al. Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A Meta-analysis of Randomized Clinical Trials. Diabetes Care 2011;34:2474–2476
por: Yamagishi, Sho-ichi
Publicado: (2012)

Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Yamagishi, Sho-ichi
Publicado: (2013)

Structural Abnormality or Vascular Dysfunction? A Road to Ruin
por: Yamagishi, Sho-ichi
Publicado: (2016)

Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillation
por: Yamagishi, Sho-ichi
Publicado: (2019)

Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study
por: Oyama, Jun-ichi, et al.
Publicado: (2016)

Formulation and characterization of orodispersible tablet of glimepiride
por: Kinani, Ahmad AB Yosef, et al.
Publicado: (2022)

Hypercholesterolemia Causes Circadian Dysfunction: A Potential Risk Factor for Cardiovascular Disease
por: Akashi, Makoto, et al.
Publicado: (2017)

Takotsubo Syndrome After Additional Right Ventricular Lead Insertion in a Pacemaker User
por: Yoshioka, Goro, et al.
Publicado: (2022)

Advanced glycation end products, oxidative stress and diabetic nephropathy
por: Yamagishi, Sho-ichi, et al.
Publicado: (2010)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
por: Yamagishi, Sho-ichi, et al.
Publicado: (2018)

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Glimepiride: evidence-based facts, trends, and observations
por: Basit, Abdul, et al.
Publicado: (2012)

Formulation and Evaluation of New Glimepiride Sublingual Tablets
por: Al-Madhagi, Wafa, et al.
Publicado: (2017)

Erratum: Formulation and characterization of orodispersible tablet of glimepiride
Publicado: (2023)

Sulfur-containing spiroketals from Breynia disticha and evaluations of their anti-inflammatory effect
por: Nakashima, Ken-ichi, et al.
Publicado: (2023)

Cryptochrome and Period Proteins Are Regulated by the CLOCK/BMAL1 Gene: Crosstalk between the PPARs/RXR [Formula: see text]-Regulated and CLOCK/BMAL1-Regulated Systems
por: Nakamura, Koh-ichi, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_h2a66s9v40tk64c8kbu5umardf